BioCentury | Nov 23, 2015
Company News

Eisai, University of Liverpool, Liverpool School of Tropical Medicine deal

...research on compounds that may be effective in artemisinin-resistant malaria. The partnership will focus on E209...
BioCentury | May 24, 2004
Strategy

Pharma vs. chemicals

...of UCB's pharma and chemicals businesses 1999-2003 1999 2000 2001 2002 2003 CAGR UCB Pharma E209...
BioCentury | Mar 6, 2000
Finance

Best of both worlds

...up from £18.8 million at year end. Genset (NM:Genset; GENXY) increased E20.5 (11 percent) to E209...
Items per page:
1 - 3 of 3